Vitamin E in diabetes-associated cognitive dysfunction: mechanistic rationale, current evidence and translational gaps

Diabetes-associated cognitive dysfunction (DACD) is an increasingly recognized complication of diabetes mellitus and involves multiple interacting processes, including oxidative stress, neuroinflammation, synaptic dysfunction, impaired insulin signaling, and neurovascular dysfunction. Vitamin E, a lipid-soluble antioxidant comprising tocopherols and tocotrienols, has attracted interest because several of its biological actions are mechanistically relevant to these pathways. This mini-review provides a focused overview of the mechanistic rationale, current experimental and clinical evidence, and major translational gaps concerning vitamin E in DACD. Preclinical studies suggest that specific vitamin E isoforms and preparations may modulate oxidative stress and lipid peroxidation, inflammatory signaling and microglial activation, synaptic plasticity-related pathways, and insulin responsiveness, and may also influence neurovascular processes. However, much of this evidence derives from animal models, cellular systems, peripheral tissues, or disease settings other than DACD and therefore provides mechanistic rather than clinical efficacy evidence. Direct clinical evidence in patients with formally diagnosed DACD remains lacking. Small intervention studies in patients with type 2 diabetes have reported inconsistent cognitive outcomes, whereas observational associations between dietary vitamin E intake and cognition are largely derived from non-DACD populations and cannot establish causality. High-dose supplementation may also entail safety concerns. Thus, current evidence supports the biological plausibility of vitamin E as a candidate for further investigation but does not establish its preventive or therapeutic efficacy in DACD. DACD-specific randomized controlled trials are needed to determine whether particular vitamin E isoforms, doses, or intervention durations provide clinically meaningful cognitive benefits and to establish long-term safety.

Authors

Institutions

Publication Details

Journal
Frontiers in Nutrition
Published
2026-10-28
DOI
https://doi.org/10.3389/fnut.2026.1901124
Primary Topic
Antioxidant Activity and Oxidative Stress
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vitamin E in diabetes-associated cognitive dysfunction: mechanistic rationale, current evidence and translational gaps

Peng Li, Hua Shao, Renjun Lv, Di Zhang et al.
Frontiers in Nutrition
Antioxidant Activity and Oxidative Stress
article

Vitamin E in diabetes-associated cognitive dysfunction: mechanistic rationale, current evidence and translational gaps

Peng Li, Hua Shao, Renjun Lv, Di Zhang, Wenting Geng, Yihan Fan
article en

Abstract

Diabetes-associated cognitive dysfunction (DACD) is an increasingly recognized complication of diabetes mellitus and involves multiple interacting processes, including oxidative stress, neuroinflammation, synaptic dysfunction, impaired insulin signaling, and neurovascular dysfunction. Vitamin E, a lipid-soluble antioxidant comprising tocopherols and tocotrienols, has attracted interest because several of its biological actions are mechanistically relevant to these pathways. This mini-review provides a focused overview of the mechanistic rationale, current experimental and clinical evidence, and major translational gaps concerning vitamin E in DACD. Preclinical studies suggest that specific vitamin E isoforms and preparations may modulate oxidative stress and lipid peroxidation, inflammatory signaling and microglial activation, synaptic plasticity-related pathways, and insulin responsiveness, and may also influence neurovascular processes. However, much of this evidence derives from animal models, cellular systems, peripheral tissues, or disease settings other than DACD and therefore provides mechanistic rather than clinical efficacy evidence. Direct clinical evidence in patients with formally diagnosed DACD remains lacking. Small intervention studies in patients with type 2 diabetes have reported inconsistent cognitive outcomes, whereas observational associations between dietary vitamin E intake and cognition are largely derived from non-DACD populations and cannot establish causality. High-dose supplementation may also entail safety concerns. Thus, current evidence supports the biological plausibility of vitamin E as a candidate for further investigation but does not establish its preventive or therapeutic efficacy in DACD. DACD-specific randomized controlled trials are needed to determine whether particular vitamin E isoforms, doses, or intervention durations provide clinically meaningful cognitive benefits and to establish long-term safety.

Frontiers in NutritionVol. 13
Shandong University of Traditional Chinese Medicine (CN), Shandong Provincial Hospital (CN), Shandong Provincial QianFoShan Hospital (CN), Shandong First Medical University (CN)
Good health and well-being
Openalex Percentile: Top 14%
Antioxidant Activity and Oxidative Stress
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon